Back

Complement Factor D is an independent prognostic marker in patients with chronic kidney disease in the UK-Biobank

29 August 2025 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Renal and cardiovascular disease (1) Renal Failure and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Martin Berger

RWTH University Hospital Aachen, Aachen (Germany)

5 More presentations in this session

Presentation thumbnail
Correlation between renal function level and ventricular remodeling, and mechanistic study of slc10a6-mediated ventricular remodeling after chronic kidney disease
Mr W. Zhang (Guangzhou, CN)
Abstract Slides
Presentation thumbnail
Canagliflozin in patients with type 2 Diabetes and CKD experiencing deterioration in eGFR to <20 ml/min/1.73m2 in the CREDENCE Trial
Doctor S. Chatur (Boston, US)
Abstract Slides
Presentation thumbnail
Understanding arteriovenous fistula physiology: preoperative and early postoperative effects on left ventricular myocardial work
Doctor A. Safak Arslanhan (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Impact of statin therapy on mortality in chronic kidney disease patients without atherosclerotic cardiovascular disease: insights from american and chinese cohorts (MIMIC-IV and CIN-II Databases)
Mr W. Zhang (Guangzhou, CN)
Abstract Slides
Presentation thumbnail
Unique amino acid profile and prognostic significance of the Fischer ratio in end-stage kidney disease patients with cardiovascular disease
Assistant Professor K. Moribayashi (Miyazaki, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Renal and cardiovascular disease (1)

The Event

Event poster

ESC Congress 2025

29 August 2025 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Complement factor D deficiency ameliorates adverse cardiac remodelling by inhibiting C5a-C5aR mediated ISGs+ neutrophil activation post myocardial infarction
thumbnail
Congress Presentation
Impact of chronic kidney disease on the association of vascular endothelial growth factor D with cardiovascular mortality in patients with suspected or known coronary artery disease: the ANOX study
thumbnail
Congress Session
Caring for kidney disease patients in a cardiology setting: what is important?

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources